ILLUMINA INC (ILU.DE) Stock Price, Forecast & Analysis

Europe • Frankfurt Stock Exchange • FRA:ILU • US4523271090

124.06 EUR
-3.32 (-2.61%)
Last: Jan 29, 2026, 07:00 PM

ILU.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap18.96B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Shares152.80M
Float152.49M
52 Week High132.16
52 Week Low62
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)3.66
PE33.9
Fwd PE28.57
Earnings (Next)02-05
IPO2000-06-28
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
ILU.DE short term performance overview.The bars show the price performance of ILU.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40

ILU.DE long term performance overview.The bars show the price performance of ILU.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of ILU.DE is 124.06 EUR. In the past month the price increased by 8.46%. In the past year, price decreased by -3.7%.

ILLUMINA INC / ILU Daily stock chart

ILU.DE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ILU.DE. When comparing the yearly performance of all stocks, ILU.DE turns out to be only a medium performer in the overall market: it outperformed 60.75% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ILU.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE. ILU.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ILU.DE Financial Highlights

Over the last trailing twelve months ILU.DE reported a non-GAAP Earnings per Share(EPS) of 3.66. The EPS increased by 152.02% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.39%
ROA 11.38%
ROE 29.53%
Debt/Equity 0.42
Chartmill High Growth Momentum
EPS Q2Q%17.54%
Sales Q2Q%0.37%
EPS 1Y (TTM)152.02%
Revenue 1Y (TTM)-2.32%

ILU.DE Forecast & Estimates

27 analysts have analysed ILU.DE and the average price target is 111.36 EUR. This implies a price decrease of -10.24% is expected in the next year compared to the current price of 124.06.

For the next year, analysts expect an EPS growth of 96.09% and a revenue growth -0.88% for ILU.DE


Analysts
Analysts73.33
Price Target111.36 (-10.24%)
EPS Next Y96.09%
Revenue Next Year-0.88%

ILU.DE Ownership

Ownership
Inst Owners104.7%
Ins Owners0.17%
Short Float %N/A
Short RatioN/A

About ILU.DE

Company Profile

ILU logo image Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.

Company Info

ILLUMINA INC

5200 Illumina Way

San Diego CALIFORNIA US

Employees: 9000

ILU Company Website

ILU Investor Relations

Phone: 18582024500

ILLUMINA INC / ILU.DE FAQ

What does ILLUMINA INC do?

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.


What is the current price of ILU stock?

The current stock price of ILU.DE is 124.06 EUR. The price decreased by -2.61% in the last trading session.


Does ILLUMINA INC pay dividends?

ILU.DE does not pay a dividend.


How is the ChartMill rating for ILLUMINA INC?

ILU.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Where is ILLUMINA INC (ILU.DE) stock traded?

ILU.DE stock is listed on the Frankfurt Stock Exchange exchange.